Iron Metabolism Physiology and Deficiency
Iron homeostasis is tightly regulated: dietary non-haem iron (Fe3+) requires reduction to Fe2+ by duodenal cytochrome B (DcytB) and gastric acid before DMT1-mediated enterocyte uptake; haem iron enters via separate HCP1 transporter. Intracellular iron is either stored as ferritin (24-subunit shell binding 4,500 iron atoms) or exported via ferroportin (FPN1/SLC40A1) into plasma. Hepcidin (hepatic peptide hormone; HAMP gene) is the master iron regulator: high iron or inflammation (IL-6→JAK2/STAT3) drives hepcidin upregulation, which binds FPN1 causing internalisation and degradation, trapping iron in enterocytes and macrophages (“anaemia of chronic disease”). Iron deficiency anaemia (IDA) is the most prevalent micronutrient deficiency globally: ~2 billion affected; hallmarks include MCV <80 fL, MCH <27 pg, ferritin <12 μg/L, transferrin saturation <16%.
Spirulina Mechanisms in Iron Metabolism
Phycocyanin Iron Chelation and DMT1 Absorption Enhancement
Spirulina iron (28–32 mg/100g dry weight) is partially chelated within phycocyanin tetrapyrrole ring systems in a Fe2+-like coordination geometry. This chelation protects iron from Fe2+→Fe3+ oxidation in the alkaline duodenal environment (>pH 6.5, where free Fe2+ rapidly oxidises to poorly-absorbed Fe3+), maintaining it in an absorbable form. In the presence of phycocyanin iron complexes, DMT1-mediated iron transport efficiency improves +20–30% vs. equivalent doses of free ferric iron (FeSO4 equivalents) in Caco-2 intestinal absorption models. Spirulina vitamin C (~10–15 mg/100g) further reduces Fe3+ to Fe2+, providing complementary absorption enhancement.
Anti-Inflammatory Hepcidin Suppression
Hepcidin is the primary barrier to iron absorption in inflammation: IL-6 (from adipose, macrophages, inflamed tissue) activates STAT3 in hepatocytes, upregulating HAMP gene transcription. Elevated hepcidin (normal: 5–20 ng/mL; elevated in anaemia of chronic disease: 50–200 ng/mL) internalises FPN1 in enterocytes, Kupffer cells, and macrophages, preventing iron mobilisation despite adequate stores. Spirulina phycocyanin reduces systemic IL-6 by 20–35% via NF-κB inhibition, lowering hepatic STAT3 activation and hepcidin transcription. Result: hepcidin falls 20–35%, restoring FPN1 surface expression and enabling iron export from enterocytes and macrophage iron recycling pools into circulation.
Ferritin Upregulation and Safe Storage
Ferritin heavy chain (FTH) is a Nrf2 target gene: ARE sequences in the FTH1 promoter enable Nrf2-mediated transcriptional upregulation in response to oxidative or electrophilic signals. Spirulina Nrf2 activation increases ferritin H-chain expression +15–25%, increasing cellular iron sequestration capacity. High ferritin protects against: (1) Fenton reaction (Fe2+ + H2O2 → OH⋅); (2) labile iron pool (LIP) pro-oxidant activity; (3) inflammatory iron-driven NF-κB activation. Ironically, ferritin upregulation protects against cellular iron toxicity — relevant in haemochromatosis risk reduction and during high-dose iron supplementation co-supplementation.
Transferrin and Plasma Iron Transport
Spirulina magnesium (~0.8–1.5 mg Mg per 10g) and copper (∼0.5–0.8 mg/100g) support ceruloplasmin ferroxidase activity (Cu-containing enzyme oxidising Fe2+→Fe3+ for transferrin loading in plasma). Without adequate ceruloplasmin activity (acaeruloplasminaemia), iron cannot be loaded onto transferrin for tissue delivery despite normal gut absorption. Spirulina copper provision maintains ferroxidase capacity, enabling efficient plasma iron transport to marrow erythroid precursors for haemoglobin synthesis.
Clinical Outcomes in Iron-Deficiency Anaemia
- Haemoglobin (IDA): +1.0–1.5 g/dL at 12 weeks
- Serum ferritin: +15–30 ng/mL
- Transferrin saturation: +4–8% absolute
- Hepcidin: −20–35%
- Reticulocyte count: +15–25%
- Iron absorption (59Fe tracer): +20–30% vs. free iron dose
Dosing and Drug Interactions
IDA prevention/mild treatment: 5–10g daily for 12–16 weeks; combine with vitamin C-rich food. Oral iron supplementation: Spirulina hepcidin reduction may improve iron supplement efficacy; GI tolerability is better with food-form iron. Haemochromatosis (iron overload): Spirulina contains iron and should be used cautiously; ferritin upregulation is beneficial but total iron load must be monitored. Erythropoiesis-stimulating agents: Spirulina addresses iron supply side; ESAs address erythropoietic demand side; complementary. Summary: Absorption +20–30%, hepcidin −20–35%, ferritin +15–25%, Hb +1.0–1.5 g/dL; dosing 5–10g for 12–16 weeks. NK concern: low.